Merck Electronics KGaA

Activities: Drug Delivery Research & Development Dosage Forms

At Merck we translate science and technology into internal innovation and external collaborations with the goal to have the power to change lives. Now more than ever, we’re keeping digitalization at the forefront of it all

Trending Articles

  1. AstraZeneca invests $3.5bn into its US pharmaceutical research and manufacturing capabilities The company will expand its biologics manufacturing, as well as its speciality manufacturing and cell therapy production capacity, while also extending its pharmaceutical...
  2. The importance of accurate tare/gross weighing systems in the pharmaceutical industry Why accurate tare/gross weighing is critical in pharmaceutical settings
  3. IMed Consultancy enabling innovation in the mental healthcare sector with Limbic Limbic is a London-based start-up that is using world-leading, clinically validated Artificial Intelligence and beautiful product design to make psychological therapy...
  4. Romaco showcases its solid dosage processing portfolio at CPHI & PMEC India The company will display its portfolio suitable for the granulation, tableting, and coating of pharmaceutical solids
  5. Lonza expands bioconjugation capabilities for ADC manufacturing at Visp site The CDMO's facility will double its bioconjugate manufacturing capacity with two 1,200 L manufacturing suites

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Drug Delivery

Curia and MilliporeSigma sign deal for use of cell line for proteins and antibodies

Following this agreement, the CHOZN GS-/- cell line has been integrated into Curia’s cell line development workflow and is immediately available to Curia customers
Drug Delivery

Merck invests €290m in biosafety testing capacity

The company aims to increase its Group sales to approximately €25 billion by 2025
Manufacturing

Merck opens commercial facility in France

The Martillac facility is designed to operate at the highest levels of efficiency and can rapidly pivot from 200 to 2000 litres of drug substance
Ingredients

Merck expands granulated excipient line for pharma products

The company has launched a multi-compendial excipient with broad application in both pharma and biopharma
Manufacturing

MilliporeSigma adds full viral vector contract services with new platform

This new launch has made it one of the first CDMOs and technology developers to provide a full viral vector manufacturing offering including AAV, Lentiviral, CDMO, CTO, and process development
Analysis

Merck launches Mobius Multi Column Capture System for intensified fed-batch or perfusion monoclonal antibody production

Continuous chromatography decreases the volume of resin required by up to 99%
Manufacturing

Merck opens $63m CDMO facility to handle HPAPIs

The industry expert has announced that its Life Science business sector has doubled its highly potent active pharmaceutical ingredients (HPAPI) production capacity with the expansion of this facility
Subscribe now